NASDAQ: HTFL
Heartflow Inc Stock

$29.90-0.09 (-0.3%)
Updated Aug 12, 2025
HTFL Price
$29.90
Fair Value Price
N/A
Market Cap
N/A
52 Week Low
$26.56
52 Week High
$31.69
P/E
N/A
P/B
N/A
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-0.34
Operating Cash Flow
N/A
Beta
-3.33
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

HTFL Overview

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company's platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. The company was founded in 2007 and is headquartered in Mountain View, California.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine HTFL's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Health Information Service

Industry Rating
A
HTFL
Ranked
#34 of 44

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$19.58A
$18.67A
$72.09A
View Top Health Information Service Stocks

Be the first to know about important HTFL news, forecast changes, insider trades & much more!

Overview

Due Diligence Score

Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HTFL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

HTFL's short-term assets ($144.64M) exceed its short-term liabilities ($43.41M)
Short-term Liabilities Financials
HTFL's long-term liabilities ($261.46M) exceed its short-term assets ($144.64M)
Long-term Liabilities Financials
HTFL's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
There are 30 more HTFL due diligence checks available for Premium users.

Valuation

HTFL's financial health

Profit margin

Revenue
$37.2M
Net Income
-$32.3M
Profit Margin
-86.9%

Assets to liabilities

Assets
$184.4M
Liabilities
$304.9M
Debt to equity
-0.34
HTFL's short-term assets ($144.64M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HTFL's long-term liabilities ($261.46M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HTFL's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
HTFL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$13.2M
Investing
-$1.1M
Financing
$72.9M

HTFL vs Health Information Service Stocks

TickerZen RatingMarket Cap1d %P/EP/B
AMWLC$114.03M-1.53%-0.88x0.40x
BTSGB$3.85B+5.13%63.88x2.21x
BFRGD$12.05M+0.79%-1.58x3.71x
CCLDB$107.07M-1.17%-63.25x1.91x
ACON$4.24M-0.11%-0.00x0.27x

Heartflow Stock FAQ

What is Heartflow's quote symbol?

(NASDAQ: HTFL) Heartflow trades on the NASDAQ under the ticker symbol HTFL. Heartflow stock quotes can also be displayed as NASDAQ: HTFL.

If you're new to stock investing, here's how to buy Heartflow stock.

What is the 52 week high and low for Heartflow (NASDAQ: HTFL)?

(NASDAQ: HTFL) Heartflow's 52-week high was $31.69, and its 52-week low was $26.56. It is currently -5.66% from its 52-week high and 12.58% from its 52-week low.

How much is Heartflow's stock price per share?

(NASDAQ: HTFL) Heartflow stock price per share is $29.90 today (as of Aug 12, 2025).
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.